Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SEMAGLUTIDE Cause Concomitant disease aggravated? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Concomitant disease aggravated have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.0% of all adverse event reports for SEMAGLUTIDE.

6
Reports of Concomitant disease aggravated with SEMAGLUTIDE
0.0%
of all SEMAGLUTIDE reports
1
Deaths
2
Hospitalizations

How Dangerous Is Concomitant disease aggravated From SEMAGLUTIDE?

Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does SEMAGLUTIDE Cause?

Nausea (10,036) Vomiting (6,518) Off label use (5,425) Diarrhoea (5,331) Decreased appetite (4,317) Constipation (4,036) Weight decreased (3,518) Impaired gastric emptying (2,622) Product use in unapproved indication (2,613) Wrong technique in product usage process (2,538)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which SEMAGLUTIDE Alternatives Have Lower Concomitant disease aggravated Risk?

SEMAGLUTIDE vs SEMUSTINE SEMAGLUTIDE vs SENNA LEAF SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B SEMAGLUTIDE vs SENNOSIDES SEMAGLUTIDE vs SENNOSIDES A AND B

Related Pages

SEMAGLUTIDE Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated SEMAGLUTIDE Demographics